Studies should focus on determining the role of SESN2 in osteosarcoma cells with a particular focus on autophagy and its potential effects on drug resistance, and the underlying molecular mechanism of chemotherapy-driven SESN2-mediated autophagy in osteosarcoma also needs to be explored. Here, SESN2 is linked to osteosarcoma.